A Japanese Phase 1 Trial of c-Met Inhibitor MSC2156119J in Subjects With Solid Tumors
Status:
Completed
Trial end date:
2014-10-31
Target enrollment:
Participant gender:
Summary
This is a Japanese multicenter, open-label, Phase 1 study to evaluate safety and efficacy of
MSC2156119J in subjects with malignant solid tumor which is refractory to standard therapy or
to which no effective standard therapy is applicable.